Mechanisms, Causes, and Effects of Hypercapnia
UptoDate Dec, Feller-Kopman, D.J. & Schwartzstein, R.M., 2016
Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008
Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999
Severe Polymyositis-Like Syndrome Associated with Zidovudine Therapy of AIDS & ARC
NEJM 318:708, Bessen,L.J.,et al, 1988
Penicillamine-Induced Myositis
Am J Med 77:719-722, Halla,J.T.,et al, 1984
Dysphagia and a rash
BMJ 361:k1590, McFarlane, M. & Disney, B., 2018
Inflammatory Muscle Diseases
NEJM 372:1734-1747, Dalakas, M.C., 2015
Correlation of Clinicoserologic and Pathologic Classifications of Inflammatory Myopathies
Medicine 92:15-24, Fernandez, C.,et al, 2013
Inflammatory Myopathies with Anti-Ku Antibodies
Medicine 91:95-102, Rigolet,A.,et al, 2012
A Case of Necrotizing Myopathy with Proximal Weakness and Cardiomayopathy
Neurol 78:1527-1532, Matthews,E.,et al, 2012
Clinicopathologic Conference, Thymoma with Paraneoplastic Myasthenia Gravis, Polymyositis and Myocarditis, and Brain Stem Encephalitis
NEJM 365:2413-2422, Case 39-2011, 2011
Sjogren Syndrome: Neurologic Complications
www.Medlink.com,Jan, Roman,G.C., 2010
Evaluation and Treatment of Inflammatory Myopathies
JNNP 80:1060-1068, Amato,A. &Barohn,R.J., 2009
Polymyositis Masquerading as Motor Neuron Disease
Arch Neurol 60:1001-1003, Ryan,A.,et al, 2003
Polymyositis and Dermatomyositis
Lancet 362:971-982, Dalakas,M.C.&Hohlfeld,R., 2003
Treatment of Inflammatory Myopathies
Muscle & Nerve 20:651-664997., Mastaglia,F.L.,et al, 1997
Intravenous Immunoglobulin Treatment of Neurological Disease
JNNP 60:359-361, Otten,A.,et al, 1996
Congenital Muscular Dystrophy with Primary Laminin a2 (Merosin) Deficiency Presenting as Inflammatory Myopathy
Ann Neurol 40:782-791, Pegoraro,E.,et al, 1996
Neurologic Aspects of Inflammatory Bowel Disease
Neurol 45:416-421, Lossos,A.,et al, 1995
Myositis:Immunologic Contributions to Understanding Cause, Pathogenesis, and Therapy
Ann Int Med 122:715-724, Plotz,P.H.,et al, 1995
Acute Neuromuscular Respiratory Paralysis
JNNP 56:334-343, Hughes,R.A.C.&Bihari,D., 1993
Drug Therapy of Idiopathic Inflammatory Myopathies:Response to Prednisone Azathioprine, & Methotrexate
Am J Med 94:379-387, Joffe,M.M.,et al, 1993
Controlled Trial of Plasma Exchange and Leukapheresis in Polymyositis and Dermatomyositis
NEJM 326:1380-1384, Miller,F.W.,et al, 1992
Immunologic Aspects of Neurological and Neuromuscular Diseases
JAMA 268:2918-2922, Zweiman,B.&Levinson,A.I., 1992
Facioscapulohumeral Dystrophy, In Skeletal Muscle Pathology
Churchhill Livingstone, NY, p285, 30392., Mastaglia,F.L.&Walton,J., 1992
Polymyositis Mediated by T Lymphocytes that Express the y/8 Receptor
NEJM 324:877-881, Hohlfeld,R.,et al, 1991
Efficacy of Intravenous Gammaglobulin Therapy in Chronic Refactory Polymyositis & Dermatomyositis:20 Adult Patients
Am J Med 91:162-168, Cherin,P.,et al, 1991
The Idiopathic Inflammatory Myopathies and Their Treatment
JNNP 54:285-287, Walton,J., 1991
Polymyositis, Dermatomyositis, and Inclusion-Body Myositis
NEJM 325:1487-1498, Dalakas,M.C., 1991
Cyclosporin in the Management of Polymyositis and Dermatomyositis
JNNP 54:1007-1008, Lueck,C.J.,et al, 1991
Clinical Uses of Intravenous Immunoglobulins
Ann Int Med 112:278-292, Berkman,S.A.,et al, 1990
Current Concepts in the Idiopathic Inflammatory Myopathies:Polymyositis, Dermatomyositis, and Related Disorders
Ann Int Med 111:143-157, Plotz,P.H.,et al, 1989
HTLV-1 Associated Myelopathy and Polymyositis in a US Native
Neurol 39:1572-1575, Evans,B.K.,et al, 1989
Facioscapulohumeral Muscular Dystrophy, in Neuromuscular Disease
Springer-Verlag, NY, p289988., Swash,M.&Schwartz,M.S., 1988
Inflammatory Myopathies
Ann Neurol 17:215-227, 317-3231985., Mastaglia,F.L.,et al, 1985
Presentation, Treatment, & Prognosis of Idiopathic Inflammatory Muscle Disease in a Rural Hospital
Am J Med 75:433-438, Hoffman,G.S.,et al, 1983
Inflammatory Facioscapulohumeral Muscular Dystrophy & Coats Syndrome
Ann Neurol 12:398-401, Wulff,J.D.,et al, 1982
Phenytoin Hypersensitivity:38 Cases
Neurol 29:1480-1485, Harunda,F., 1979
Eosinophilic Polymyositis
Ann Neurol 1:65, Layzer,R.B.,et al, 1977
Cause of Weakness in Myasthenia Gravis
NEJM 294:722, Grob,D., 1976
Adult Toxoplasmosis Presenting as Polymyositis & Cerebellar Ataxia
Ann Int Med 82:367, Greenlee,J.,et al, 1975
Polymyositis & Dermatomyositis
NEJM 292:344, 1975, 292:403975., Bohan,A.,et al, 1975
Quadriceps Myopathy-Entity or Syndrome
Arch Neurol 31:60, Boddie,H.,et al, 1974
Neurologic Manifestations of Progressive Systemic Sclerosis, 1972
Nebraska Med J 58:106, Aita,J.A., 1973
The Incidence of the Non-Metastatic Neurological Syndromes of Obscure Origin in the Reticuloses
Brain 93:629, Currie,S.,et al, 1970
Diseases of Muscles-Clinical Manifestations & Differential Diagnosis
The New Physic 263, 1967, Oct., Boshes,L., 1967
The Remote Effects of Cancer on the Nervous System
Proc Roy Soc Med 60:683, Wilkinson,M., 1967
Polymyositis
Neurol 61:316-321, van der Meulen,M.F.G.,et al, 2003
Women With Pregnancy-related Polymyotis and High Serum CK Levels in the Newborn
Neurol 58:482-484, Messina,S.,et al, 2002